Johnson & Johnson (JNJ)
Johnson & Johnson stock today
Johnson & Johnson closed at $273.20 on October 30, 2026, down 0.73% on the day. Over the past year it returned +47.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $658 billion.
| Period | JNJ | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.2% | -0.9% |
| 3 months | +7.3% | +2.1% |
| Year to date | +34.1% | +11.7% |
| 1 year | +47.8% | +12.4% |
| 3 years | +102.3% | +88.5% |
| 5 years | +92.8% | +76.0% |
Key statistics
- Market value
- $658B
- P/E (trailing)
- 41.5
- Forward P/E
- 23.8
- Price / sales
- 6.6
- Dividend yield
- 1.93%
- 52-week range
- $186.00 to $278.43
About Johnson & Johnson
Develops, manufactures, and sells pharmaceuticals, medical devices, and consumer health products.
Sector: Health Care · Industry: Pharmaceuticals
More on Johnson & Johnson
- Financials: revenue, earnings and segmentsRevenue +6% in the year to Dec 2025
- Valuation: P/E history and peersP/E 41.5, median 23.9 at its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $3,108 today
No forecast, no recommendation. This page describes Johnson & Johnson from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.